European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer. (Q33346175)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer. |
scientific article |
Statements
European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer (English)
Christian Manegold
Channa Debruyne
Rabab Gaafar
Erika Buchholz
Egbert F Smit
Pilar Lianes
Guul ten Velde
Lionel Bosquee
Catherine Legrand
Carlo Neumaier
Kathrine King
Giuseppe giaccone European organization for research and treatment of cancer (EORTC) lung cancer group
1 January 2003